Cogent Biosciences Investors

20 investors on Angel Roster list Cogent Biosciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, France and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Cogent Biosciences can appear together.

Investors listed
20
With verified email
45%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 20 Cogent Biosciences investors

The most complete profiles first. Showing 20 of 20.

  • Jernej GodecVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Kevin BittermanVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more

    Verified email available

  • Alex HardingVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Catherine PoulinVerified

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Verified email available

  • Jason P. HaflerVerified

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Jason RhodesVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Laia CrespoVerified

    Venture Capital, Corporate Venture Capital, Investor · France

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Verified email available

  • Ron HuntVerified

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Verified email available

  • Bruce Booth

    Venture Capital, Angel/Individual

    SeedHealthcare DeliveryWellnessBiotechnologyConsumer Health

    Portfolio: Nimbus Therapeutics, Magenta Therapeutics, Bicycle Therapeutics, Miragen Therapeutics and 13 more

    Contact details available

  • Alain J. Gilbert

    Private Equity Firm, Investment Partner · France

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Craig Slutzkin

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Daniel Mansuri

    Corporate Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more

    Contact details available

  • James Niedel

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Jean

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Contact details available

  • Jeffrey Ives

    Venture Capital · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Marc

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Rebecca Luse

    Venture Capital · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Steven Robinette

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Contact details available

  • Vijay Lathi

    Venture Capital, Private Equity Firm · United States

    Health CareCybersecurityMessagingWomen Founded

    Portfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more

    Contact details available

  • Eric RichmanVerified

    Angel/Individual, Investment Partner · United States

    Biotechnology

    Portfolio: Cogent Biosciences

    Verified email available

Frequently asked questions

How many Cogent Biosciences investors are on Angel Roster?

Angel Roster lists 20 Cogent Biosciences investors. 9 of them (45%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (14), Private Equity Firms (8) and Investment Partner Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Cogent Biosciences investors invest in?

Among those that list a stage, the most common are Series B (2) and Seed (1).

Where are Cogent Biosciences investors based?

Most are based in the United States (15), France (2) and Canada (2).

Which companies have Cogent Biosciences investors backed?

The most-backed portfolio companies among them are UNUM Therapeutics (19), Kymera Therapeutics (10), Navitor Pharmaceuticals (9), Intellia Therapeutics (9) and Lysosomal Therapeutics (9).

How do I contact Cogent Biosciences investors?

Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.